Tag: Frontotemporal Dementia

Latest News

NIH-funded research consortium aims to advance treatments for frontotemporal lobar degeneration

Newsemia
The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic and the University...
Neurology

Researchers uncover potential clue to halt destruction of nerve cells in people with ALS

Newsemia
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis...
Neurology

Scientists develop technique to clear abnormal tau protein from human neurons

Newsemia
Harnessing a probe used to image the brain in diagnosing Alzheimer’s disease and related forms of dementia, scientists at Dana-Farber Cancer Institute and Massachusetts General...
Latest News

Scientists determine normal function of gene associated with ALS and FTD

Newsemia
The normal function of a gene associated with the neurodegenerative diseases amyotrophic lateral sclerosis and frontotemporal dementia has been determined for the first time by...
Neurology

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Newsemia
Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1...
Neurology

Study shows that rogue proteins may underlie some ALS and frontotemporal dementia cases

Newsemia
ALS — amyotrophic lateral sclerosis — is a neurodegenerative disease that attacks motor neurons in the brain and spinal cord, slowly robbing its victims of...
Latest News

Study provides new clues to connection between aging and neurodegeneration

Newsemia
For decades researchers have worked to shed light on the causes of neurodegenerative disorders, a group of devastating conditions, including Alzheimer’s and Parkinson’s, that involve...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy